Also, an exchange programme for researchers of both the countries to learn from each other in the fields of infection and neurological diseases will be initiated.
"France and India share a long tradition of cooperation in sciences and technology based on more than 60 years of history. The exchange research programme will help in finding the possible advanced treatments in the field of cardiovascular and neurological treatment," said Jean Marie, President of FAM, addressing media.
"This conclave has given us an opportunity to gain an insight into the medical development and innovations which shall prove to be mutually beneficial," said AIIMS Director M C Mishra.
However, as per AIIMS, the medicine is currently in trial and will take a year at least to be available in the market.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
